Rianne Ellenbroek

Rianne Ellenbroek is a principal at BGV (BioGeneration Ventures) and has accumulated 15 years of extensive experience in venture capital, technology transfer, biotechnology, and academia. Currently, Rianne serves on various boards and committees, including roles at VectorY, Phlox Therapeutics, and the Nederlandse Vereniging van Participatiemaatschappijen. Previously, Rianne was an investment manager for the FIRST fund and held postdoctoral research positions at The University of Chicago and Leiden University Medical Center. Rianne's educational background includes a PhD from Leiden University, where they earned accolades for their research in diabetes.